Lucid Diagnostics (LUCD) EPS (Diluted) Growth (1y) (2023 - 2026)
Lucid Diagnostics (LUCD) EPS (Diluted) Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 13.96% |
| 10 | Lucid Diagnostics | 176.72 Mn | 143.31 Mn | 55,000.00 | -70.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -70.71% |
| Mar 31, 2026 | 58.33% |
| Dec 31, 2025 | 34.05% |
| Sep 30, 2025 | 60.86% |
| Jun 30, 2025 | 65.09% |
| Mar 31, 2025 | -30.15% |
| Dec 31, 2024 | 11.91% |
| Sep 30, 2024 | 27.64% |
| Jun 30, 2024 | 16.10% |
| Mar 31, 2024 | -1.44% |
| Dec 31, 2023 | 37.15% |
| Sep 30, 2023 | 13.89% |
| Jun 30, 2023 | 33.47% |